BML Capital Management LLC Purchases 50,000 Shares of Vistagen Therapeutics, Inc. (NASDAQ:VTGN)

BML Capital Management LLC grew its position in shares of Vistagen Therapeutics, Inc. (NASDAQ:VTGN – Free Report) by 50.0% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 150,000 shares of the company’s stock after buying an additional 50,000 shares during the quarter. […]

Leave a Reply

Your email address will not be published.

Previous post Broadband outages costing UK economy £17.6bn – but compensation is nowhere to be seen
Next post BML Capital Management LLC Has $2.91 Million Stake in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP)